Literature Case Analysis of 44 Patients with Thrombocytopenia Induced by Clopidogrel / 医药导报
Herald of Medicine
; (12): 304-308, 2024.
Article
Dans Zh
| WPRIM
| ID: wpr-1023714
Responsable en Bibliothèque :
WPRO
ABSTRACT
Objective To investigate the characteristics of clopidogrel-associated thrombocytopenia to provide references for clinically safe drug use.Methods The case reports of thrombocytopenia induced by clopidogrel published in PubMed,Embase,CNKI,Wanfang and VIP were searched from the establishment of each database to November 2022,and their occurrence was collated and analysed.Results A total of 44 cases from 43 articles were identified and included in the analysis.There were 30 males(68.2%)and 14 females(31.8%).Ages ranged from 37 to 88(65.0±11.4)years,of which 30(68.2%)were ≥60 years old.Thrombocytopenia was found from 8 h to 9 months after medication,of which 29 cases(65.9%)appeared within two weeks.There were 31 cases(70.5%)with severe thrombocytopenia and 38 cases(86.4%)with complications,of which 24 cases(63.2%)with bleeding and 19 cases(50.0%)with thrombotic thrombocytopenic purpura(TTP).The platelet countof41 cases(93.2%)returned to normal after drug withdrawal and symptomatic treatment,and 3 cases(6.8%)died finally.Conclusion Clopidogrel related thrombocytopenia is mainly severe thrombocytopenia,and often accompanied by bleeding or thrombotic thrombocytopenic purpura(TTP),but the overall outcome is good.Platelet count should be regularly monitored within the first two weeks after medication.Clopidogrel should be stopped and symptomatic treatment should be given in case of any abnormality.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Herald of Medicine
Année:
2024
Type:
Article